
An AI-driven drug discovery company leveraging AlphaFold to accelerate therapeutic development.
Isomorphic Labs is an AI-driven drug discovery company founded by Demis Hassabis in 2021 as a spin-off from DeepMind. The company utilizes advanced AI models, including AlphaFold, to predict protein structures and interactions, aiming to revolutionize the drug discovery process. By modeling complex biological systems, Isomorphic Labs seeks to design novel therapeutics more efficiently. The company has established partnerships with pharmaceutical giants like Eli Lilly and Novartis and secured $600 million in funding to advance its mission of accelerating therapeutic development.
76/100
Our subjective rating of how independently the product carries out its documented tasks, considering the human setup, input, approval and review it needs. This is not a measured success rate.
Loading Community Opinions...
Show prospects that Isomorphic Labs has a public place where they can check product details, pricing, ratings, and reviews.
Build confidence
Give buyers a third-party profile to explore.
Reduce hesitation
Put validation beside your strongest CTA.
Earn discovery
Every badge links prospects to your listing.
Choose your style
Preview it, then copy the complete embed code.
Shows buyers where to validate your product, pricing, and reputation.
Plain HTML. No signup, script, or maintenance required.
For drug discovery research teams
Exploring Isomorphic Labs? For drug discovery research teams, your own AI agent can map target literature, reconcile screening evidence, and prepare discovery research packs. Start with a setup tailored to this work.
Tailored starting setup. Chat on our site. See the workflow and monthly plan.